BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20969585)

  • 1. Surprising new roles for PU.1 in the adaptive immune response.
    Carotta S; Wu L; Nutt SL
    Immunol Rev; 2010 Nov; 238(1):63-75. PubMed ID: 20969585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors.
    Laiosa CV; Stadtfeld M; Xie H; de Andres-Aguayo L; Graf T
    Immunity; 2006 Nov; 25(5):731-44. PubMed ID: 17088084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models in the study of the Ets family of transcription factors.
    Bartel FO; Higuchi T; Spyropoulos DD
    Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of PU.1 in hematopoiesis.
    Fisher RC; Scott EW
    Stem Cells; 1998; 16(1):25-37. PubMed ID: 9474745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualizing PU.1 activity during hematopoiesis.
    Back J; Allman D; Chan S; Kastner P
    Exp Hematol; 2005 Apr; 33(4):395-402. PubMed ID: 15781329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner.
    Carotta S; Dakic A; D'Amico A; Pang SH; Greig KT; Nutt SL; Wu L
    Immunity; 2010 May; 32(5):628-41. PubMed ID: 20510871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
    Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
    Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C.
    DeKoter RP; Geadah M; Khoosal S; Xu LS; Thillainadesan G; Torchia J; Chin SS; Garrett-Sinha LA
    J Immunol; 2010 Dec; 185(12):7374-84. PubMed ID: 21057087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
    Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
    Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor.
    Dahl R; Walsh JC; Lancki D; Laslo P; Iyer SR; Singh H; Simon MC
    Nat Immunol; 2003 Oct; 4(10):1029-36. PubMed ID: 12958595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
    Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
    Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
    Houston IB; Huang KJ; Jennings SR; DeKoter RP
    Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PU.1 binding site is a cis-element that regulates pro-B/pre-B specificity of Vkappa-Jkappa joining.
    Hayashi R; Takemori T; Kodama M; Suzuki M; Tsuboi A; Nagawa F; Sakano H
    J Immunol; 1997 Nov; 159(9):4145-9. PubMed ID: 9379006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.
    Su GH; Chen HM; Muthusamy N; Garrett-Sinha LA; Baunoch D; Tenen DG; Simon MC
    EMBO J; 1997 Dec; 16(23):7118-29. PubMed ID: 9384589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell development in PU.1-deficient mice.
    Spain LM; Guerriero A; Kunjibettu S; Scott EW
    J Immunol; 1999 Sep; 163(5):2681-7. PubMed ID: 10453009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin is dispensable for hematopoiesis and lymphopoiesis.
    Cobas M; Wilson A; Ernst B; Mancini SJ; MacDonald HR; Kemler R; Radtke F
    J Exp Med; 2004 Jan; 199(2):221-9. PubMed ID: 14718516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired repressor activity and biological functions of PU.1 in MEL cells induced by mutations in the acetylation motifs within the ETS domain.
    Kihara-Negishi F; Suzuki M; Yamada T; Sakurai T; Oikawa T
    Biochem Biophys Res Commun; 2005 Sep; 335(2):477-84. PubMed ID: 16098914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.